GlobeNewswire Press Release

TORRANCE, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) — Criminal IP, a globally recognized Cyber Threat Intelligence (CTI) solution by AI SPERA, has launched its Criminal IP Malicious Link Detector add-in on the Microsoft Marketplace. This cutting-edge tool provides real-time phishing email detection and URL blocking for Microsoft Outlook, adding an essential layer…

FUQUAY-VARINA, N.C., Jan. 09, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Longleaf Meadow, is coming soon to Fuquay-Varina, North Carolina. This exclusive Toll Brothers neighborhood will include just 47 single-family home sites offering top-tier options for personalization at the…

NORCROSS, Ga, Jan. 09, 2025 (GLOBE NEWSWIRE) — PruittHealth, a family-owned and Georgia-based provider of post-acute care, today announced the purchase of two new health care centers from industry leader Debbie Meade and her Georgia-based organization Health Management. PruittHealth took over the operations of Eastview Nursing Center in Macon and Southern Pines Nursing…

A new year provides fresh opportunities for people and industries. For those at the Regina and Saskatoon airports, it is an exciting time to welcome travellers. A busy holiday travel season in the winter followed by a new flight out of Regina to a major American hub in the spring…

MONTREAL, Jan. 09, 2025 (GLOBE NEWSWIRE) — BranditScan & FansRevenue have announced their shared premium sponsorship of the highly anticipated X3 Expo event show, taking place from January 17-18, 2025. Located at booth #113, BranditScan and FansRevenue invite models and attendees to experience an exciting and interactive space designed to…

BERWYN, Pa., Jan. 09, 2025 (GLOBE NEWSWIRE) — AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today launched its latest Specialty & Rare Pipeline Digest™, the industry’s most comprehensive digital resource for information on new, pending and upcoming specialty and rare disease drug launches, biosimilars…

Exit mobile version